Fish Oil Products: Do The Serving Sizes Add Up to Cholesterol Benefits?
Omega-3 fatty acids, including eicosapentaenoic acid (EPA) and docosehexaenoic acid (DHA), have been found to be associated with cardiovascular health benefits.
Dyslipidemia
Carotid Plaque Instability Risk Higher in Women With Metabolic Syndrome, Hypertriglyceridemia
This study aimed to assess the effects of the various elements of metabolic syndrome on carotid plaque destabilization.
Bempedoic Acid Decreases Lipid Levels Among Patients With Hyperlipidemia
In a review and meta-analysis, investigators evaluated the novel fatty acid inhibitor bempedoic acid as a possible treatment for hyperlipidemia.
Remnant Cholesterol Predicts Cardiovascular Events Among Patients With Coronary Artery Disease
Austrian researchers investigated the utility of remnant cholesterol as a marker of cardiovascular event risk in coronary artery disease.
Dyslipidemia Drug Indications
Comparative chart of single and combination treatment options indicating which lipids can be targeted for dyslipidemias.
Inclisiran Safe, Effective in Reducing LDL-C in Patients With Familial Hypercholesterolemia or ASCVD
Researchers conducted a patient-level pooled analysis from phase 3 trials of inclisiran in patients with familial hypercholesterolemia or ASCVD.
Managing the Interplay of Familial Hypercholesterolemia and COVID-19
About 90% of those with familial hypercholesterolemia have not been diagnosed or treated for it, leaving them more vulnerable for COVID-19 infection and its complications.
Machine Learning With Novel Lipid Parameters Improved FH Classification
Machine learning was used to develop a model incorporating multiple biomarkers that improved the classification of familial hypercholesterolemia.
Alirocumab Approved for Homozygous Familial Hypercholesterolemia
The approval was based on data from the phase 3 ODYSSEY HoFH trial, which evaluated Praluent in 69 adults with HoFH who were on other LDL-C-lowering therapies.
Low HDL-C and Greater HDL-C Variability Linked to Higher Risk of Parkinson Disease
A team of researchers investigated the longitudinal association between high HDL-C levels, HDL-C variability, and the risk of developing Parkinson disease.
- Loading...
Loading...
Next post in General Cardiology
Loading... 
Loading...